Diabetes Collaboration Initiative of the Year

Do you work in a collaborative partnership that has improved or changed the treatment and management of diabetes for adults?

Healthcare providers, social care, patient associations, charities, non-governmental agencies and pharmaceutical companies can improve outcomes for people with diabetes, through

high-quality, cost-effective treatment and management.

Collaborations across traditional sector boundaries provide opportunities to improve patient outcomes through joint working to ensure that patients get optimal care, with support to help them maximise the benefits of treatment across health and social care.

Eligible work will demonstrate joint development and implementation of patient-centred projects together with shared commitment to successful delivery. These initiatives may have operated at a local or national level.

This award will recognise outstanding collaborative projects that demonstrate working with internal and external stakeholders to achieve a common goal, ie initiatives created and implemented by multi-organisational partnership: for example, work carried out by teams comprising NHS, charities social care etc. that significantly contribute to self-management, avoidance of complications and treatment of diabetes.

Entries should demonstrate clear, specific goals with outcomes that have been evaluated using appropriate baseline and follow-up measures. There should be evidence of innovation, and detail of project planning, methods, effectiveness, timeliness, safety considerations, economic viability and evidence of potential/demonstrable sustainability and dissemination.

Entries to this category could include:

  • Collaborative working between health, social care teams, charities and patient groups
  • Service referral and key relationships
  • Clinical collaboration:
    • Long-term care planning for multiple and complex illnesses
    • Collaboration between primary and specialist care to identify diabetes issues early and avoid long-term complications
    • Community collaboration initiatives
    • Patient safety initiatives
  • Non-traditional collaborations eg technology, IT and communications
  • Clinical Commissioning Group partnerships eg prevention, safety initiatives
  • Local authority/government partnerships
  • Digital and technology initiatives: should be UK or Ireland based (even if they are used globally). Work must have been conducted during the 18-month period between July 2016 and December 2017 to be eligible

Scoring criteria, judges will be looking for evidence of:


Scoring criteria, judges will be looking for evidence of:

Section

Title

Section score

Guidance on content

Section 7

Main Outcomes

Max 35 points from 3 subsections

For this category the judges are primarily interested in the innovation and collaborative aspects of your initiative. This is highlighted in the first section of the submission statement.

A

Summary

5

Background, brief overview of the initiative

B

Innovation

15

Demonstrate evidence of innovation: what is new and different about your initiative eg novel collaborations, creative solutions to traditional barriers to collaborative working.

C

Collaboration

15

Demonstrate strong leadership and collaboration partnerships to delivers solutions supporting improved diabetes services and outcomes.

Section 8

Planning & Methods

Max 30 points from 3 subsections

This section provides further details of how the initiative was developed

A

Project Planning

10

Describe the identified need for the initiative. Organisation, stakeholders, planned timeframes and milestones. Evidence of clear, specific goals and outcome measures including reasoning behind these. How did you involve service users?

B

Methods

10

Putting plans into action. What did you do? Describe how the initiative was Implemented, and outline the procedures and tools you used to measure outcomes.

C

Safety Considerations

10

Describe risk assessment, clinical governance, ethics and any other safety considerations and how these were addressed.

D

RESULTS

Max 35 points divided between 5 quality improvement areas

This section provides detail of results for the outcomes described in section 8A-8C above, along with user feedback, economic viability and potential or achieved impact

1

Effectiveness

10

Demonstrate effectiveness of project to illustrate efficiency improvement(s) how the initiative brought about change to support improved outcomes and what was the impact for people with diabetes?

2

Timeliness

5

Did you achieve your goals in desired/required time frame?

3

User feedback

5

Describe how feedback was collected and bias was minimised. Provide examples of service user feedback and explain how this is used.

4

Cost efficiency and economic viability

5

Maximising quality health outcomes and minimising NHS costs, getting better value from the NHS budget.

5

Sustainability and evidence for sharing practice  and dissemination

10

Detail of potential or secured commitment to the initiative including length of plan, resources, stakeholders, funding sources. For demonstrable sustainability describe integration, compatibility, barriers encountered, evaluation and milestones.


Achieved spread of initiative to wider geographical areas or other healthcare settings. Include details of strategy, communication of outcomes, key messages, objectives and evaluation undertaken.


  • KEY DATES
  • Launch at Diabetes UK Professional Conference 2018:
    14 March
  • Judging day: 19 July
  • Awards ceremony: 18 October
QiC Diabetes is partnered by:
Supported by: